Showing results (11-20 of 104) with videos related to
Sort By:
Pageof 11
Annals of Hematology|October 31, 1998
Low-molecular-weight heparin-induced skin necrosisW Füreder, P A Kyrle, H Gisslinger, et al.Circulation|May 1, 1987
Inhibition of prostacyclin and thromboxane A2 generation by low-dose aspirin at the site of plug formation in man in vivoP A Kyrle, H G Eichler, U Jäger, et al.Journal of Thrombosis and Haemostasis : JTH|April 14, 2017
Risk of cancer after anticoagulation in patients with unprovoked venous thromboembolism: an observational cohort studyL Eischer, M Kammer, L Traby, et al.Wiener Klinische Wochenschrift|March 19, 1982
[New aspects of chlorprothixen-poisoning (author's transl)]M Fuhrmann, K Hruby, K Lenz, et al.Journal of Cardiovascular Pharmacology|August 1, 1989
Cilazapril and enalapril inhibit local angiotensin I conversion in human veins but lack direct venodilating propertiesH G Eichler, B Blöchl-Daum, P A Kyrle, et al.Journal of Thrombosis and Haemostasis : JTH|October 10, 2007
Chemotherapy-induced thrombin generation via procoagulant endothelial microparticles is independent of tissue factor activityD Lechner, M Kollars, A Gleiss, et al.Thrombosis Research|November 26, 1999
The Factor V (Leiden) test: evaluation of an assay based on dilute Russell Viper Venom Time for the detection of the Factor V Leiden mutationP Quehenberger, S Handler, C Mannhalter, et al.Blood|August 15, 1994
Variant Bernard-Soulier syndrome associated with a homozygous mutation in the leucine-rich domain of glycoprotein IXJ M Clemetson, P A Kyrle, B Brenner, et al.Annals of Hematology|October 22, 2008
6 versus 30 months anticoagulation for recurrent venous thrombosis in patients with high factor VIIIL Eischer, V Gartner, S Schulman, et al.Journal of Thrombosis and Haemostasis : JTH|April 19, 2007
von Willebrand factor/factor VIII concentrate (Haemate P) dosing based on pharmacokinetics: a prospective multicenter trial in elective surgeryS Lethagen, P A Kyrle, G Castaman, et al.Pageof 11